Summary
The product Primobolan 100, manufactured by Unique Pharma, was independently tested for authenticity and potency. The sample, identified by batch number UN55337, was submitted by Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of Methenolone Enanthate, with a result of 101.14 mg/ml, slightly exceeding the labeled claim of 100 mg/ml by 1.14%.
The testing process began on 18 October 2022, with the sample received on 26 October 2022, and analysis completed on 27 October 2022. While the findings confirm accurate dosing, potential biases from reseller-submitted samples warrant independent validation to ensure product consistency. This report aims to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Primobolan 100
- Active Ingredient: Methenolone Enanthate
- Batch Number: UN55337
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #25043
- Testing Ordered: 18 October 2022
- Sample Received: 26 October 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Labeled Specification: 100 mg/ml
- Measured Concentration: 101.14 mg/ml
- Accuracy: 101.14% (1.14% above the labeled claim)
Verification Details
- Verification URL: https://janoshik.com/tests/25043_HVJL6U8169BQ
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
The analysis confirms that Primobolan 100 meets its labeled potency with a slight overdosing, indicating good quality control for this batch. However, as the sample was submitted and funded by the reseller, Opitropin.EU, there is a potential for bias. Resellers may choose high-quality batches for testing that do not represent broader product consistency. To ensure transparency and reliability, independent third-party testing across multiple batches is recommended.
Conclusion
The test confirms that Primobolan 100 contains 101.14 mg/ml of Methenolone Enanthate, slightly exceeding the labeled dosage. This reflects strong quality control for this batch, though further testing is encouraged to validate consistency across the product line. This report supports harm reduction and helps consumers make informed decisions.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases but provides useful data when critically evaluated alongside independent third-party results. Readers are advised to use this information responsibly.
